Please login to the form below

Not currently logged in
Email:
Password:

Glyxambi

This page shows the latest Glyxambi news and features for those working in and with pharma, biotech and healthcare.

AZ gets US approval for diabetes combo Qtern

AZ gets US approval for diabetes combo Qtern

It is the second combination of its type to be approved for marketing in the US after Eli Lilly and Boehringer Ingelheim's Glyxambi (linagliptin/empagliflozin). ... At one point the UK group suggested Qtern would become a $3bn product at peak, but the

Latest news

More from news
Approximately 3 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics